Cambria Investment Management’s Pfizer PFE Stock Holding History

Cambria Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Buy	429,762 +55,869	+15%	+$1.46M	0.51%	35
2026 Q1	$10.5M	Buy	373,893 +6,465	+2%	+$172K	0.59%	18
2025 Q4	$9.15M	Sell	367,428 -30,319	-8%	-$765K	0.53%	37
2025 Q3	$10.1M	Buy	397,747 +30,156	+8%	+$744K	0.62%	40
2025 Q2	$8.91M	Sell	367,591 -55,014	-13%	-$1.28M	0.6%	68
2025 Q1	$10.7M	Buy	+422,605	New	+$11.1M	0.75%	52
2016 Q2	–	Sell	-48,308	Closed	-$1.36M	–	185
2016 Q1	$1.36M	Sell	48,308 -4,922	-9%	-$141K	0.63%	82
2015 Q4	$1.63M	Sell	53,230 -3,446	-6%	-$108K	0.65%	63
2015 Q3	$1.69M	Sell	56,676 -14,274	-20%	-$458K	0.65%	63
2015 Q2	$2.26M	Buy	70,950 +492	+0.7%	+$16K	0.69%	62
2015 Q1	$2.33M	Buy	70,458 +3,445	+5%	+$110K	0.26%	65
2014 Q4	$1.98M	Buy	+67,013	New	+$1.92M	0.71%	77

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cambria Investment Management's PFE Position: Q2 2026 in Review

Cambria Investment Management increased its Pfizer (PFE) stake by 15% in Q2 2026, buying an estimated $1.46M and bringing the position to 429,762 shares worth $10.3M. The position accounts for 0.51% of the portfolio, ranked #35.

Cambria Investment Management first reported a position in PFE in Q4 2014 and has held it in 12 quarters since. The position peaked at $10.7M in Q1 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cambria Investment Management held 429,762 shares of Pfizer worth $10.3M as of Q2 2026.
Cambria Investment Management bought 55,869 Pfizer shares in Q2 2026, an estimated $1.46M.
Pfizer made up 0.51% of Cambria Investment Management's portfolio in Q2 2026, its #35 holding.
Cambria Investment Management first reported a position in Pfizer in Q4 2014 and has held it in 12 quarters since.
Cambria Investment Management's Pfizer position peaked at $10.7M in Q1 2025.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.